Report Content
Chapter 1 Methodology & Scope
1.1 Methodology
1.2 Market scope & definitions
1.3 Base estimates and calculations
1.3.1 North America
1.3.2 Europe
1.3.3 Asia Pacific
1.3.4 Latin America
1.3.5 MEA
1.4 Forecast calculations
1.5 Data validation
1.6 COVID-19 impact analysis at global level
1.7 Data sources
1.7.1 Secondary
1.7.1.1 Paid sources
1.7.1.2 Unpaid sources
1.7.2 Primary
Chapter 2 Executive Summary
2.1 Photopheresis products market industry 3600synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Product type trends
2.1.4 Application trends
2.1.5 End-use trends
Chapter 3 Photopheresis Products Industry Insights
3.1 Industry segmentation
3.2 Industry ecosystem analysis
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Rise in prevalence of autoimmune diseases
3.3.1.2 Growing incidence of cutaneous T-cell lymphoma
3.3.1.3 Increased government reimbursement policies and growing private healthcare insurance
3.3.1.4 Technological advancements in photopheresis products
3.3.2 Industry pitfalls & challenges
3.3.2.1 High cost involved in therapy
3.3.2.2 Lack of photopheresis treatment centers
3.4 Growth potential analysis
3.4.1 By product type
3.4.2 By application
3.4.3 By end-use
3.5 COVID- 19 impact analysis
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive landscape
4.1 Introduction
4.2 Company matrix analysis, 2021
4.3 Competitive dashboard
4.4 Company market share, 2021
4.5 Competitive analysis of major market players
4.6 Competitive positioning matrix
4.7 Strategic outlook matrix
Chapter 5 Photopheresis Products Market and Forecast, By Product Type (USD Million)
5.1 Key trends, by product type
5.2 Open system
5.3 Closed system
Chapter 6 Photopheresis Products Market and Forecast, By Application (USD Million)
6.1 Key trends, by application
6.2 Graft versus host disease
6.3 Cutaneous T-cell lymphoma
6.4 Transplant rejections
6.5 Autoimmune diseases
Chapter 7 Photopheresis Products Market and Forecast, By End-use (USD Million)
7.1 Key trends, by end-use
7.2 Hospitals
7.3 Ambulatory surgical centers
7.4 Others
Chapter 8 Photopheresis Products Market and Forecast, By Region (USD Million)
8.1 Key regional trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Russia
8.3.7 Poland
8.3.8 Switzerland
8.3.9 Norway
8.3.10 Finland
8.3.11 Sweden
8.3.12 Denmark
8.3.13 The Netherlands
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Vietnam
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Colombia
8.5.5 Chile
8.6 Middle East & Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Israel
Chapter 9 Company Profiles
9.1 Thermo Fisher Scientific
9.2 Haemonetics Corporation
9.3 Fresenius Kabi
9.4 Terumo Corporation
9.5 Macopharma
9.6 Mallinckrodt Pharmaceuticals
9.7 Med Tech Solutions GmbH
9.8 Spectranetics
9.9 Therakos
